US health officials are issuing emergency clearance to a technique for extending the supply of monkeypox vaccine made by
The action will allow the US Food and Drug Administration to “exercise additional authorities that may increase availability of vaccines to prevent monkeypox while continuing to ensure the vaccine meets high standards for safety, effectiveness and manufacturing quality,” Department of Health and Human Services Secretary
The Bavarian Nordic monkeypox vaccine.
Photographer: Kobi Wolf/Bloomberg
The dose-sparing strategy involves injecting the vaccine, called Jynneos, into the upper layer of the skin, rather than beneath it. The approach ...